Sanofi and CD&R sign Opella share purchase agreement Paris, February 19, 2025. Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the ...
Zacks.com on MSN16h
IONS’ Better-Than-Expected Q4 ResultsEC approves MRK's Welireg for two indications. FDA grants priority review to SNY and REGN's Dupixent sBLA for bullous pemphigoid.
While Sanofi's list price of Aubagio is set at £13,529 ($22,100) per patient a year, NICE was able to recommend it for the NHS after Sanofi made the drug available at a discount under the patient ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
This can be found among the Granolas, a group of 11 European multinationals, selected by US bank Goldman Sachs, which is made ...
The week has ended with a flurry of M&A in the drug industry, with Cosette Pharmaceuticals agreeing to buy Australia's Mayne ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Altuvoct (efanesoctocog alfa) to be used to ...
Advisers scored lucrative roles on deals in 2024 including Sanofi’s consumer healthcare sale and the take-private of UK cyber ...
The use of digital twins with industrial, manufacturing and architectural use cases is well known, and in the manifold ...
Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...
The leading Advanced Melanoma Companies such as OncoSec Medical, Immunocore, Sanofi, TILT Biotherapeutics, Novartis ...
Many supporters are unsettled by turbulent modern times and yearn for a return to a stable past. Read more at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback